Clinical Trial Update: Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients. [Phase 1]

View source ↗

Summary

A Phase 1 dose-seeking trial of PCK3145 in asymptomatic, castration-resistant metastatic prostate cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• PCK3145

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED